A recent study by Yang et al. [94] provided the first evidence that both SIRT3 gene and protein expression are significantly decreased in gastric cancer patients, suggesting that SIRT3 may have a role as a mitochondrial tumour suppressor in this disease via its direct control of HIF-1α. The gene discussed is SIRT3; the disease is neoplasm.